(Hypertension. 2001;37:917.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Departments of Medicine (F.C., A.D., P.S., G.F., I.B.), Pharmacology (I.B.), and Anesthesiology (B.J.), Vanderbilt University, Nashville, Tenn. Dr Costa is now at the American Heart Association, National Center, Dallas, Tex.
Correspondence to Italo Biaggioni, MD, 1500 21th Avenue S, Suite 3500, Vanderbilt University, Nashville, TN 37212-8210. E-mail Italo.biaggioni{at}mcmail.vanderbilt.edu
| Abstract |
|---|
|
|
|---|
Key Words: exercise microdialysis muscles sympathetic nervous system
| Introduction |
|---|
|
|
|---|
Given the excitatory effects of adenosine on other afferent fibers, it has been suggested that adenosine also activates muscle afferents involved in the exercise pressor reflex. This reflex arises in part from afferent fibers located in the skeletal muscle that are activated by metabolites generated by intense exercise, triggering a reflex that results in sympathetic activation and increased blood pressure (BP).7 8
We previously suggested that endogenous adenosine contributes to the activation of muscle afferents involved in the exercise pressor reflex in humans,9 in part based on the observation that intra-arterially administered adenosine produces reflex sympathetic activation by stimulating forearm afferents.6 Some investigators have provided independent confirmation of these findings,10 11 but others have expressed concern that the sympathetic activation may be explained by a spillover of adenosine into the systemic circulation with the activation of peripheral arterial chemoreceptors.12 13 Controversy also has arisen about the ability of adenosine to activate myocardial afferents.14 15
In the present study, we used complementary approaches to test the hypothesis that adenosine activates forearm afferent fibers. First, to discriminate whether the effects of intrabrachial adenosine are due to the activation of forearm muscle afferents or to spillover into the systemic circulation with activation of peripheral receptors, we used axillary ganglionic blockade to determine whether the interruption of forearm afferent nerve traffic suppresses the sympathetic activation induced by intrabrachial adenosine. We also compared the magnitude and onset latency of the sympathetic activation induced by intravenous and intrabrachial injections of adenosine. Finally, we measured interstitial concentrations of adenosine in the forearm muscle while monitoring muscle sympathetic nerve activity (MSNA) to determine the relationship between these variables to the intensity of exercise and the presence of ischemia. We used a microdialysis probe, which allows the passage of only low-molecular-weight molecules,16 to estimate interstitial adenosine levels.
| Methods |
|---|
|
|
|---|
72
hours before the study. The protocol was approved by the Vanderbilt
University Institutional Review Board. Volunteers were informed of the
characteristics of the study and gave written consent.
Instrumentation
For each study session, subjects were fasted and in
the supine position. Heart rate was monitored with surface ECG coupled
to a rate computer. A catheter was inserted into the right antecubital
vein for drug administration. When indicated, an indwelling catheter
was placed into the brachial artery for intra-arterial drug
administration and connected through 3-way valves to a pressure
transducer. BP was measured continuously from the brachial artery or
through finger plethysmography (Finapres2300; Ohmeda).
Cardiovascular signals were modulated on signal
conditioners and displayed on a thermal array recorder (model
TA6000; Gould Inc) or digitized with a Windaq system (DA-220; DATAQ
Instruments).
Axillary Ganglionic Blockade
The left brachial plexus was blocked using an
axillary perivascular approach. With the left humerus abducted 90°
and in full external rotation, the axillary artery was palpated in the
arm, and a 1% lidocaine skin wheal was placed over the artery under
sterile conditions. A 22-gauge, 1.5-inch needle was advanced toward the
axillary artery pulsation until the hub of the needle was observed to
exhibit triphasic pulsations. The needle was then advanced proximally
0.5 cm parallel to the axillary artery while the triphasic pulsations
were maintained. Tubing was then connected to the needle hub, and 40 mL
of 1% lidocaine was intermittently injected with frequent, careful
aspiration and monitoring of vital signs. The needle was then removed,
and a sterile dressing was applied. The subject was questioned
regarding the onset of paresthesias and observed for the onset of
vasodilation, cutaneous warmth, and loss of
proprioception.
Transcutaneous Muscle Microdialysis
A microdialysis probe, CMA/20 (CMA), was introduced
into the flexor digitorium superficialis muscle of the left forearm, as
previously described in
detail.17 18 19
The probe had a dialysis tubing (10x0.5 mm with a 20 000
molecular mass cutoff) and was perfused continuously with saline at a
rate of 2 µL/min ("perfusate") with a microinjection pump
(CMA/102 Microdialysis Pump). The effluent ("dialysate") was
recovered with a fraction collector. The in vitro recovery of
adenosine from microdialysis
probes18 averaged 36±6% in
these studies.
Microneurography
MSNA was recorded from the right peroneal nerve,
as previously described,20
and digitized with a Windaq system (DA-220; DATAQ Instruments).
Previously published criteria for an adequate MSNA
recording20 were
followed.
Protocol 1: To Determine Whether Axillary
Ganglionic Blockade, Which Interrupts Forearm Afferent Traffic,
Suppresses Sympathetic Activation Induced by Intrabrachial
Adenosine
In 5 subjects, an intrabrachial catheter was placed
for drug administration, and microneurography was performed as
described earlier. The subjects rested for 20 minutes after
instrumentation. BP and MSNA were monitored continuously. Intrabrachial
boluses of either saline or adenosine (1, 2, and 3 mg) were
then administered in a randomized and single-blinded fashion, with
venous occlusion as described earlier. Time was allowed between doses
for MSNA and BP to return to baseline levels. To test the effectiveness
of ganglionic blockade, cold pressor test was performed by placing the
hand in ice water for 1 minute. BP and MSNA were recorded. We
performed axillary ganglionic blockade as described, and the preceding
protocol (intrabrachial injections of adenosine and the cold
pressor test) was then repeated.
Protocol 2: To Determine Differences in
Magnitude and Latency of Onset of Sympathetic Activation Between
Intrabrachial and Intravenous Adenosine
Administration
Volunteers were instrumented so we could monitor
MSNA, BP, and heart rate, as described. Bolus injections of either 3 mg
adenosine or saline were administered either
intravenously, intrabrachially, intrabrachially during
venous occlusion, or intrabrachially during arterial
occlusion. The injections were single-blinded, and the order was
randomized. Venous occlusion was induced by inflating a proximal
pneumatic cuff to 50 mm Hg immediately before injection and
maintaining inflation for 2 minutes while data were
collected.9
Arterial occlusion was induced immediately before
intrabrachial injections by inflating a proximal pneumatic cuff to
50 mm Hg above systolic BP and maintaining inflation for
2 minutes.
Protocol 3: To Examine the Effect of Varying
Exercise Intensity and Superimposed Ischemia on Muscle
Interstitial Levels of Adenosine and Reflex
Sympathetic Activation
In 8 subjects, a microdialysis probe was inserted in
the forearm, and microneurography was set up, as previously described.
After a 1-hour equilibration period, 2 consecutive 15-minute dialysate
samples were collected to determine resting adenosine levels.
Subjects were then asked to perform intense dynamic handgrip at 50% of
maximal voluntary contraction (MVC) for 15 minutes (5-second
contractions at 10-second intervals). One 15-minute dialysate sample
was collected during handgrip. Immediately after the release of
handgrip, a proximal pneumatic cuff on the upper arm was inflated to
50 mm Hg above systolic BP and maintained for 2 minutes
(posthandgrip circulatory arrest). Two consecutive 15-minute recovery
dialysate samples were collected immediately after exercise. MSNA was
recorded continuously.
Subjects returned 3 weeks later for a second study day with a similar setup and protocol. Three interventions were performed in random order, 1 hour apart (1) dynamic handgrip at 15% MVC for 15 minutes followed by posthandgrip circulatory arrest, (2) dynamic handgrip at 15% MVC for 5 minutes, followed by posthandgrip circulatory arrest, and (3) dynamic handgrip at 15% MVC for 5 minutes while ischemia was superimposed with a proximal pneumatic cuff inflated to 50 mm Hg above systolic BP, followed by posthandgrip circulatory arrest. Dialysate samples were collected during each exercise period (15 or 5 minutes) and at 15-minute intervals during all resting periods. MSNA was continuously recorded. The 3 interventions included in this protocol were randomized.
Drugs
Adenosine was purchased from Sigma Chemical
Co and prepared for human use by our investigational pharmacy as a 6
mg/mL solution. Lidocaine HCl 2% (Xylocaine) was purchased from Astra
USA, Inc and dissolved in saline.
Analytical Methods and Statistical
Analysis
Adenosine samples were analyzed using
a microbore HPLC system (Isco microLC system; Isco Inc) according to
the method of Jackson et
al.18 21
For protocol 1, MSNA was determined from the original
tracings of the mean voltage neurograms using a digitizer tablet
coupled to Sigma Scan software (Jandel Scientific). The amplitude of
each "burst" was measured in millimeters, and total activity was
defined as the sum of "burst" amplitude over 60-second periods and
was expressed in arbitrary units. For protocol 2, data were
analyzed with software written in our laboratory using
PV-WAVE (Visual Numerics Inc). Bursts were detected with an
automated detection algorithm with artifact elimination, dynamic noise
level detection, and signal-to-noise estimation. Bursts were accepted
if the signal-to-noise ratio was >2:1 and synchronization to the
previous cardiac event was
1.6 seconds. To determine the latency of
onset of sympathetic activation, values for MSNA were determined at
1-second intervals, and a 10-second sliding window average was used to
generate each data point. Time 0 is the average of data from 5 seconds
before to 5 seconds after injection. The effect of a given intervention
on MSNA was expressed as percent change from the preceding resting
period. A 3-minute period before injection was used as baseline, and
the average and standard deviation values of all 1-second measurements
were calculated. For each adenosine injection, we determined
the time when MSNA exceeded a value equivalent to 2 SDs around
this average. The latency of onset was defined as the time in seconds
immediately before this threshold was reached. Individual latency of
onset times from individual intra-arterial or
intravenous adenosine injections were then
averaged.
Statistical analysis was performed using t test for single comparisons and ANOVA for multiple comparisons. Post hoc tests (Duncans) were used to determine individual differences only if significant group differences were found with ANOVA. Values of P<0.05 were considered significant. Results are expressed as mean±SEM.
| Results |
|---|
|
|
|---|
|
Axillary ganglionic blockade inhibited the increase in MSNA produced by cold exposure (from 163±46% to 4±14%) and the increase in mean BP (from 19±5 to 4±2 mm Hg), demonstrating the effectiveness of ganglionic blockade (n=5, P<0.05, Figure 1B).
Effect of the Route of Administration of
Adenosine on the Magnitude and Latency of Onset of Sympathetic
Activation
IV injections of 3 mg adenosine increased MSNA
by 67±28%, with a latency of onset of 17±3 seconds (n=14, 95% CI 12
to 23 seconds,
Figure 2A). Intrabrachial injections of adenosine
produced a greater (248±49%) and earlier (7.6±1 seconds, 95% CI 6
to 10 seconds) increase in MSNA (n=13,
Figure 2A). There was a significant difference in latency of
onset of sympathetic activation produced by intrabrachial and
intravenous adenosine injections as determined by
2-tailed unpaired t test
(P=0.0031) or
nonparametric (Mann-Whitney) test
(P=0.0015). Intrabrachial
injections of adenosine produced a mild increase in mean BP
(5.5±2.1 mm Hg at 27 seconds).
IV
adenosine did not produced significant changes in BP. Neither
IV nor intrabrachial injections of saline (placebo) affected MSNA or BP
(not shown). Likewise, there was no consistent effect of
adenosine or saline on heart rate.
|
The increase in MSNA produced by intrabrachial injections of adenosine during venous occlusion was not as pronounced but sustained, compared with that produced by intrabrachial adenosine (Figure 2B). The onset latency was similar. Intrabrachial adenosine during arterial occlusion produced a moderate and delayed increase in MSNA (115±32% at 64 seconds, n=8, Figure 2B) and a more gradual and delayed increase in mean BP (5±1.5 mm Hg at 75 seconds). Representative neurograms taken after intrabrachial and intravenous injections of adenosine are shown in Figure 2C.
Effects of Varying Exercise Intensity on Muscle
Interstitial Adenosine and MSNA
Adenosine muscle dialysate levels were higher
during intense (50% MVC) handgrip (from 0.307±0.07 to 1.237±0.42
µmol/L, 528±292% increase from baseline) compared with moderate
(15% MVC) handgrip (from 0.104±0.02 to 0.419±0.16 µmol/L,
303±99% increase, n=7,
P<0.01,
Figure 3A). The concentrations of adenosine returned
to rest levels within 30 minutes after exercise.
|
We found a greater increase in MSNA (88±25%) during intense handgrip compared with moderate handgrip (38±28%, n=7, P=0.01, Figure 3B). MSNA remained elevated during posthandgrip circulatory arrest (58±21% and 28±31% above resting levels after intense and moderate handgrip, respectively).
Effect of Combining Ischemia and
Exercise on Muscle Interstitial Adenosine and
MSNA
Adenosine dialysate concentrations increased
from 0.095±0.02 to 0.249±0.12 µmol/L during moderate dynamic
exercise and from 0.095±0.02 to 0.476±0.19 µmol/L when
ischemia was superimposed on moderate exercise (487±181% and
132±77% increase, respectively; n=7,
P=0.01,
Figure 4A). Similarly, a greater increase in MSNA was
produced when ischemia was superimposed on handgrip (74±13%
versus 40±9%, n=6, P<0.01,
Figure 4B). MSNA remained elevated during posthandgrip
circulatory arrest (47±17% after handgrip with superimposed
ischemia and 16±9% after handgrip without
ischemia).
|
There was a significant correlation between the percent increases in adenosine levels and MSNA produced by these interventions (r=0.96, P<0.01 by linear regression, Figure 5). For this analysis, we used the increase in MSNA observed during the posthandgrip circulatory arrest period because this sympathetic activity during this period is not confounded by central command or muscle mechanoreceptor activation and more closely reflects chemoreceptor activation.
|
| Discussion |
|---|
|
|
|---|
Adenosine concentrations in the muscle are reported to increase during ischemia in animal models2 22 23 and in the human myocardium and pericardium.24 25 Previous attempts to measure adenosine concentrations from total tissue or from venous samples have resulted in inconsistent results. Because most adenosine contained in the muscle is of intracellular origin,26 muscle sampling has not been helpful in estimating the amount of adenosine released into the extracellular space during exercise. In addition, the detection of any increase in interstitial adenosine is limited by cellular uptake and metabolism, mechanisms that are particularly efficient in humans.27 Consequently, the very short half-life of adenosine limits the possibility of obtaining reliable values from venous samples. Also, the endothelium constitutes an important barrier for adenosine,28 so interstitial adenosine may not completely reach the intravascular compartment; furthermore, it is likely that endothelial cells generate adenosine into the intravascular compartment.18 Adenosine determinations from venous samples therefore may not reflect muscle interstitium adenosine levels. The microdialysis technique has the advantage that the semipermeable microdialysis membrane excludes enzymes such as adenosine deaminase (molecular weight 41 kDa) that metabolize adenosine and cells that take up adenosine.16 Our results with this technique suggest that the release of adenosine during exercise is related to exercise intensity, because dialysate adenosine levels are higher during intense exercise (dynamic handgrip at 50% MVC) compared with during moderate exercise (15% MVC), and to the presence of ischemia, because dialysate concentrations of adenosine increased further when ischemia was superimposed on moderate exercise.
In addition, we found that the magnitude of sympathetic activation induced by these interventions correlated with the increase in interstitial adenosine. Parallel increases in adenosine and MSNA do not prove that one is the consequence of the other, but we have previously shown that the blockade of forearm adenosine receptors with intrabrachial theophylline blunts the exercise pressor reflex induced by sustained handgrip.9 It should be noted that forearm ischemia imposed in a resting forearm is not sufficient to induce sympathetic activation29 30 or to increase muscle interstitial adenosine.18 This suggests that both ischemia and increased metabolic demands are required to induce the release of sufficient adenosine (and perhaps other metabolites) to stimulate muscle afferents and trigger sympathetic activation.
MacLean et al12 recently proposed that the sympathetic activation induced by injections of adenosine into the femoral artery is not due to stimulation of leg muscle afferents but rather to spillover of adenosine into the systemic circulation with subsequent activation of peripheral arterial chemoreceptors. This is at variance with our conclusions. We believe the explanation of this discrepancy lies in differences in the experimental design and doses used. Their protocol called for increasing the doses of adenosine injected into the femoral artery until an "unquestionable increase in MSNA above baseline" was obtained. This resulted in the use of larger doses in their study (range 2.5 to 9 mg) compared with ours (1 to 3 mg). We agree with their conclusion that these larger doses will result in spillover into the systemic circulation and activation of peripheral chemoreceptors and sympathetic activation.20 We do not believe that the same applies to our studies. They observed an onset latency for the increase in MSNA of 15.8±0.8 seconds from the time of injection, whereas our onset latency was 8.5±1 seconds. We also found that during a 2-minute occlusion of the forearm circulation, used in this study to mimic MacLean et als protocol, the effects of intrabrachial adenosine on MSNA and BP were significantly inhibited. We speculate that when the local circulation is blocked, adenosine injected intra-arterially does not reach the muscle afferents because it remains at the site of injection and is not mobilized or distributed within the limb until the circulation is reestablished. Furthermore, our comparisons between the effects of intra-arterial and intravenous adenosine injections clearly demonstrate that under the careful conditions of our study, intrabrachial adenosine selectively activated muscle afferents in the forearm. Finally, the hypothesis that adenosine activates forearm afferents is strengthened by the fact that axillary ganglionic blockade blunted sympathetic activation induced by intrabrachial adenosine.
From the results of the present study, we conclude that adenosine is released by the skeletal muscle during dynamic handgrip and that interstitial adenosine concentrations and sympathetic activation are directly related to exercise intensity and the presence of ischemia. Furthermore, both ischemia and increased metabolic demands are required for adenosine to be released and for the triggering of sympathetic activation. These results provide additional and conclusive evidence that adenosine activates muscle afferents in humans, a finding that is in agreement with its proposed role as a metabolic trigger of the exercise pressor reflex.
| Acknowledgments |
|---|
Received June 12, 2000; first decision July 10, 2000; accepted September 12, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
I. Heinonen, S. V. Nesterov, J. Kemppainen, P. Nuutila, J. Knuuti, R. Laitio, M. Kjaer, R. Boushel, and K. K. Kalliokoski Role of adenosine in regulating the heterogeneity of skeletal muscle blood flow during exercise in humans J Appl Physiol, December 1, 2007; 103(6): 2042 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. U. Gonzales, B. C. Thompson, J. R. Thistlethwaite, A. J. Harper, and B. W. Scheuermann Forearm blood flow follows work rate during submaximal dynamic forearm exercise independent of sex J Appl Physiol, December 1, 2007; 103(6): 1950 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Dhalla, M.-Y. Wong, W.-Q. Wang, I. Biaggioni, and L. Belardinelli Tachycardia Caused by A2A Adenosine Receptor Agonists Is Mediated by Direct Sympathoexcitation in Awake Rats J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 695 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Fisher, M. P. D Bell, and M. J White Cardiovascular responses to human calf muscle stretch during varying levels of muscle metaboreflex activation Exp Physiol, September 1, 2005; 90(5): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Riksen, E. E. M. van Ginneken, P. H. H. van den Broek, P. Smits, and G. A. Rongen In vivo evidence against a role for adenosine in the exercise pressor reflex in humans J Appl Physiol, August 1, 2005; 99(2): 522 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Middlekauff and J. Chiu Cyclooxygenase products sensitize muscle mechanoreceptors in healthy humans Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1944 - H1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Koomans, P. J. Blankestijn, and J. A. Joles Sympathetic Hyperactivity in Chronic Renal Failure: A Wake-up Call J. Am. Soc. Nephrol., March 1, 2004; 15(3): 524 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gamboa, A. C. Ertl, F. Costa, G. Farley, M. L. Manier, D. L. Hachey, A. Diedrich, and I. Biaggioni Blockade of Nucleoside Transport Is Required for Delivery of Intraarterial Adenosine Into the Interstitium: Relevance to Therapeutic Preconditioning in Humans Circulation, November 25, 2003; 108(21): 2631 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hanna and M. P. Kaufman Role played by purinergic receptors on muscle afferents in evoking the exercise pressor reflex J Appl Physiol, April 1, 2003; 94(4): 1437 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hanna, S. G. Hayes, and M. P. Kaufman alpha ,beta -Methylene ATP elicits a reflex pressor response arising from muscle in decerebrate cats J Appl Physiol, September 1, 2002; 93(3): 834 - 841. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |